Active topical skin protectants

Hobson, S.T., Braue, E.H., Lehnert, E.K. (2002a). Active topical skin protectants using combinations of reactive nanoparticles and polyoxometalates or metal salts. U.S. Patent No. 6,410,603, US Patent and Trademark Office, Washington, DC. 

Catalytic bioscavengers will be part of the arsenal of medical countermeasures for prophylaxis and treatments of OP poisoning in the very near future. Next, gene therapy will offer the possibility of transitory production of humanized OP-degrading enzymes in the body. Multiple enzyme associations will be part of active topical skin protectants and decontamination tools. 

Braue, E.H. Jr., Hobson, S.T., Govardhan, C., and Khalaf, N., Active Topical Skin Protectants Containing OPAA Enzymes and CLECs, U.S. Patent 6,410,603, 25 June 2002a. 

Active Topical Skin Protectants Using Combinations of Reactive Nanoparticles and Polyoxometalates or... 

Figure 1. Formulation of Active Topical Skin Protectants by adding active compounds from different classes of active moieties into the base cream.

Braue KH., Hobson, S.T, Govardhan, C., et al., 2002. Active topical skin protectants containing OPAA and CLECS. US Patent No. US 6,410,604 Bl, June 25. 

---